Cyclin‐dependent kinase 5 (CDK5) inhibitors in Parkinson disease DOI Creative Commons
Mohammed Alrouji,

Haydar M. Al‐kuraishy,

Ali I. Al‐Gareeb

и другие.

Journal of Cellular and Molecular Medicine, Год журнала: 2024, Номер 28(11)

Опубликована: Июнь 1, 2024

Abstract Cyclin‐dependent kinase 5 (Cdk5) is a protein expressed in postmitotic neurons the central nervous system (CNS). Cdk5 activated by p35 and p39 which are neuron regulatory subunits. Cdk5/p35 complex calpain protease to form has neuroprotective effect regulating synaptic plasticity memory functions. However, exaggerated implicated different types of neurodegenerative diseases including Parkinson disease (PD). Therefore, modulation signalling may mitigate PD neuropathology. aim present review was discuss critical role pathogenesis PD, how inhibitors effectual management PD. In conclusion, overactivated involved development neurodegeneration, Cdk5/calpain such as statins, metformin, fenofibrates rosiglitazone can attenuate progression

Язык: Английский

Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle DOI
Hayder M. Al‐kuraishy, Majid S. Jabir,

Ali K. Albuhadily

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 95, С. 102233 - 102233

Опубликована: Фев. 14, 2024

Язык: Английский

Процитировано

20

BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy DOI Creative Commons

Naif H. Ali,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Journal of Cellular and Molecular Medicine, Год журнала: 2024, Номер 28(10)

Опубликована: Май 1, 2024

Parkinson's disease (PD) is a neurodegenerative disorder of the brain and manifested by motor non-motor symptoms because degenerative changes in dopaminergic neurons substantia nigra. PD neuropathology associated with mitochondrial dysfunction, oxidative damage apoptosis. Thus, modulation apoptosis growth factors could be novel boulevard management PD. Brain-derived neurotrophic factor (BDNF) its receptor tropomyosin kinase type B (TrkB) are chiefly involved neuropathology. BDNF promotes survival nigra enhances functional activity striatal neurons. Deficiency TrkB triggers degeneration accumulation α-Syn As well, BDNF/TrkB signalling reduced early phase Targeting specific activators may attenuate this review aimed to discuss potential role against In conclusion, decreased linked severity long-term complications. Activation

Язык: Английский

Процитировано

20

A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease DOI
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh

и другие.

Neurochemical Research, Год журнала: 2022, Номер 48(3), С. 745 - 766

Опубликована: Ноя. 21, 2022

Язык: Английский

Процитировано

59

Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects DOI
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, ‏Hebatallah M. Saad

и другие.

Inflammopharmacology, Год журнала: 2023, Номер 31(3), С. 1107 - 1115

Опубликована: Фев. 28, 2023

Язык: Английский

Процитировано

43

The beneficial role of autophagy in multiple sclerosis: Yes or No? DOI
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb

и другие.

Autophagy, Год журнала: 2023, Номер 20(2), С. 259 - 274

Опубликована: Сен. 15, 2023

Multiple sclerosis (MS) is a chronic progressive demyelinating disease of the central nervous system (CNS) due to an increase abnormal peripherally auto-reactive T lymphocytes which elicit autoimmunity. The main pathophysiology MS myelin sheath damage by immune cells and defect in generation oligodendrocytes. Macroautophagy/autophagy critical degradation process that eliminates dysfunctional or superfluous cellular components. Autophagy has property double-edged sword it may have both beneficial detrimental effects on neuropathology. Therefore, this review illustrates protective harmful autophagy with regard disease. prevents progression reducing oxidative stress inflammatory disorders. In contrast, over-activated associated neuropathology case use inhibitors alleviate pathogenesis MS. Furthermore, provokes activation different supporting play intricate role functions modulation regulating cell proliferation related demyelination remyelination. enhances remyelination increasing activity oligodendrocytes, astrocytes. However, induces activating microglia cells. conclusion, specific autophagic activators astrocytes, dendritic (DCs), induce against

Язык: Английский

Процитировано

42

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective DOI Creative Commons
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Αθανάσιος Αλεξίου

и другие.

Pharmacology Research & Perspectives, Год журнала: 2023, Номер 11(2)

Опубликована: Фев. 22, 2023

Parkinson's disease (PD) is the second most frequent neurodegenerative brain (NBD) after Alzheimer's (AD). Statins are common lipid-lowering agents used in management of dyslipidemia and prevention primary secondary cardiovascular diseases (CVD) events. In addition, there a controversial point regarding role serum lipids pathogenesis PD. this bargain, as statins reduce cholesterol so they affect PD neuropathology bidirectional ways either protective or harmful. not PD, but frequently disorders commonly associated with elderly population. Therefore, use that population may outcomes. Concerning potential on neuropathology, conflicts controversies against development harmful by increasing risk for review aimed to clarify precise pros cons from published studies. Many studies suggest through modulation inflammatory lysosomal signaling pathways. Nevertheless, other observations statin therapy increase diverse mechanisms including reduction CoQ10. conclusion, strong neuropathology. retrospective prospective necessary regard.

Язык: Английский

Процитировано

40

Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link DOI Creative Commons
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Yaser Hosny Ali Elewa

и другие.

Cellular and Molecular Neurobiology, Год журнала: 2023, Номер 43(6), С. 2743 - 2759

Опубликована: Апрель 19, 2023

Abstract Parkinson’s disease (PD) is one of the most common degenerative brain disorders caused by loss dopaminergic neurons in substantia nigra (SN). Lewy bodies and -synuclein accumulation SN are hallmarks neuropathology PD. Due to lifestyle changes prolonged L-dopa administration, patients with PD frequently have vitamin deficiencies, especially folate, B6, B12. These augment circulating levels Homocysteine development hyperhomocysteinemia, which may contribute pathogenesis Therefore, this review aimed ascertain if hyperhomocysteinemia play a part oxidative inflammatory signaling pathways that development. Hyperhomocysteinemia implicated neurodegenerative disorders, including triggers progression different mechanisms, stress, mitochondrial dysfunction, apoptosis, endothelial dysfunction. Particularly, linked high systemic disorders. induces immune activation stress. In turn, activated response promotes hyperhomocysteinemia. hyperhomocysteinemia-induced immunoinflammatory abnormal aggravate PD, leading more severity. Also, like nuclear factor kappa B (NF-κB) nod-like receptor pyrin 3 (NLRP3) inflammasome other intricate conclusion, involved either directly via induction degeneration or indirectly pathways.

Язык: Английский

Процитировано

39

The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases DOI Creative Commons
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Diabetology & Metabolic Syndrome, Год журнала: 2023, Номер 15(1)

Опубликована: Май 13, 2023

Abstract Human Islet amyloid polypeptide (hIAPP) from pancreatic β cells in the islet of Langerhans has different physiological functions including inhibiting release insulin and glucagon. Type 2 diabetes mellitus (T2DM) is an endocrine disorder due to relative insufficiency resistance (IR) associated with increased circulating hIAPP. Remarkably, hIAPP structural similarity beta (Aβ) can engage pathogenesis T2DM Alzheimer’s disease (AD). Therefore, present review aimed elucidate how acts as a link between AD. IR, aging low cell mass increase expression which binds membrane leading aberrant Ca 2+ activation proteolytic enzymes series events causing loss cells. Peripheral plays major role AD, high level AD risk patients. However, there no hard evidence for brain-derived Nevertheless, oxidative stress, mitochondrial dysfunction, chaperon-mediated autophagy, heparan sulfate proteoglycan (HSPG), immune response, zinc homeostasis could be possible mechanisms induction aggregation risk. In conclusion, increasing levels patients predispose them development progression Dipeptidyl peptidase 4 (DPP4) inhibitors glucagon-like peptide-1 (GLP-1) agonists attenuate by deposition hIAP.

Язык: Английский

Процитировано

39

The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation DOI Open Access

Haydar M. Al‐kuraishy,

Majid S. Jabir,

Ali K. Albuhadily

и другие.

Ageing Research Reviews, Год журнала: 2023, Номер 91, С. 102084 - 102084

Опубликована: Окт. 5, 2023

Язык: Английский

Процитировано

37

The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects DOI
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, ‏Hebatallah M. Saad

и другие.

Inflammopharmacology, Год журнала: 2023, Номер 31(4), С. 1671 - 1682

Опубликована: Май 9, 2023

Язык: Английский

Процитировано

32